We aim to characterize work exposures and illness in Badin, North Carolina--the site of an aluminum smelting facility for nearly 100 years.

To conduct focus groups and semi-structured interviews of parents with cancer - and their co-parents - about their experiences communicating with their minor children about cancer to inform the development of a communication intervention support tool.

To evaluate the feasibility and acceptability of a novel psychosocial intervention for parents with advanced cancer and their co-parents.

The purpose of this study is to find better ways to diagnose, treat and prevent cancers in children, adolescents and young adults. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

To identify treatment goals and factors that affect treatment selection for older patients with advanced melanoma through semi-structured interviews with patients and treating physicians.

This is a research study to compare quality of life (QOL) and physical function impairment among breast cancer and lymphoma survivors in Malawi to age- and sex-matched controls, using the PROMIS survey and objective performance-based measures.

The purpose of the DETECT study is to learn more about how some breast tissue features show up on a mammogram and what these features can tell us about the potential for a breast cancer diagnosis. Your participation will help us understand how the appearance of those breast tissue features is affected by hormone levels. Our objective is to collect urine samples that we will use to measure hormone levels. We will examine how hormone levels are related to breast tissue features measured from a breast cancer screening mammogram.

This study seeks to understand how best to increase knowledge about clinical trials, best way of communicating information about clinical trials, and suggestions for improving clinical trial participation particularly among African Americans (AA).

Participants in this study will be asked to give a small blood sample during a routine clinic check-up. Researchers will be looking at blood components and compare with expected venetoclax concentrations. The overall goal is to be able to use specific blood components ("biomarkers") to better optimize venetoclax doses for CLL patients.

To assess the safety of nonconforming lisocabtagene maraleucel in patients